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What is already known about this subject? 
• A decade ago, brown adipose tissue (BAT) was reported to be present and 
metabolically active in adult humans. Since then, non-shivering mild cold exposure 
has been considered a potential therapeutic tool in obesity management. 
• Chronic exposure to non-shivering cold stimulus appears to improve energy 
metabolism and metabolic health in healthy individuals and people with obesity or 
type 2 diabetes mellitus. 
What are the new findings in your manuscript? 
• A mild cold exposure at a temperature adjusted to elicit maximum non-shivering 
thermogenesis induces a modest increase in energy expenditure, which is 
maintained constant during an hour. 
• A metabolic shift on macronutrient oxidation rates to sustain cold-induced 
thermogenesis (CIT) was observed by which fat oxidation increased in parallel to a 
decrease in carbohydrate oxidation at the beginning of cold exposure. Later, an 
inverse tendency appeared by which carbohydrate oxidation increased and fat 
oxidation slightly decreased. 
How might your results change the direction of research or the focus of clinical 
practice? 
• This study suggests that mild cold exposure is not a feasible tool to induce negative 
energy balance in humans. However, pharmacological or nutraceutical continuous 
induction of maximum non-shivering thermogenesis might be a feasible target for 
weight loss. 
• The observed shift on macronutrient oxidation rates may indicate that tissues 
playing a key role on CIT (i.e. BAT and muscles) could be different during the first 






Objective: To describe the energy expenditure (EE) and macronutrient oxidation 
response to an individualized non-shivering cold exposure in young healthy adults.  
Methods: Two different groups of 44 (Study 1: 22.1±2.1 years old, 25.6±5.2 kg/m2, 34% 
men) and 13 young healthy adults (Study 2: 25.6±3.0 years old, 23.6±2.4 kg/m2, 54% 
men) participated in this study. We measured resting EE (RMR) and macronutrient 
oxidation rates, by indirect calorimetry under fasting conditions, in a warm environment 
(30-minutes) and in mild cold conditions (65-minutes, wearing a water perfused cooling 
vest set at an individualized temperature adjusted to the individuals’ shivering threshold). 
Results: In study 1, EE increased in the initial stage of cold exposure and remained stable 
for the whole cold exposure (P<0.001). Mean CIT (9.56±7.9 Kcal/h) was 13.9±11.6 
%RMR (Range: -14.8/39.9 %RMR). Carbohydrate oxidation decreased during the first 
30 minutes of the cold exposure and later recovered up to the baseline values (P<0.01) in 
parallel to opposite changes in fat oxidation (P<0.01). Results were replicated in study 2.   
Conclusions: A 1-hour mild cold exposure individually adjusted to elicit maximum non-
shivering thermogenesis induces a very modest increase in EE and a shift of 






Since brown adipose tissue (BAT) was shown to be present and metabolically active in 
adult humans in 2009 (1–4), cold-induced thermogenesis (CIT) has received considerable 
attention as a possible target for stimulating BAT and energy expenditure (EE), helping 
weight control and counteracting obesity (5). Indeed, several independent groups have 
reported that chronic exposure to non-shivering cold stimulus seems to enhance energy 
metabolism and metabolic health in healthy individuals (6) and people with obesity (7) 
or type 2 diabetes mellitus (8). Noteworthy, it remains unclear whether human BAT-
related health-benefits are explained by increases in EE or by other mechanisms beyond 
energy balance (9, 10). Moreover, there is an open debate regarding the relative 
contribution of BAT to CIT, in comparison with other thermogenic tissues such as 
skeletal muscle or white adipose tissue (11). 
CIT is produced by both non-shivering and shivering mechanisms (12). Shivering 
thermogenesis is the EE necessary to cover involuntary skeletal muscle contractions in 
response to cold, while non-shivering thermogenesis refers to the energy consuming 
process not depending on muscle contraction such as uncoupling respiration in brown 
adipocytes mitochondria (13). Although some have reported that shivering thermogenesis 
can increase EE up 5-fold above resting metabolic rate (RMR), its uncomfortable nature, 
together with the loss of motor coordination, makes it a poorly tolerated stimuli, and 
therefore, a non-plausible option to be used in clinical settings (13). On the other hand, 
non-shivering thermogenesis produces moderate increases of EE, and estimations report 
a range between 0 and 30% of the RMR in young healthy adults (13). Moreover, it has 
been argued that non-shivering thermogenesis may be comfortable enough to be 
considered a possible tool in the prevention and treatment of obesity (13). Of note, 





but more as parallel phenomenon (i.e. even at light cold stimulation shivering 
thermogenesis seems to contribute to CIT) (14), and its relative contribution to CIT can 
vary within-individuals (15). 
There is a large inter-individual variation in non-shivering thermogenesis and cold 
tolerance. Therefore, to study the responses to mild cold exposure, there is a need to 
individualize the cold stimulus  to the individuals’ cold tolerance (16, 17). van der Lans 
et al. (16) proposed to first assess a shivering threshold (i.e. lowest external temperature 
without evoking externally observable and perceived shivering) as a reference point for 
adjusting the temperature at which an individual should be exposed. Although other 
methods have been proposed such as skin temperature clamping (18) or cold perception 
adjusting (19), the lowest tolerable temperature above the shivering threshold has been 
broadly accepted and used as a valid approach to induce BAT activation and CIT (17, 20–
23). Some studies have however shown that skeletal muscle thermogenesis takes place 
with very mild cold stimuli before observing shivering (14). As a result, the shivering 
threshold approach may not fully exclude the skeletal muscle shivering thermogenesis.  
Research has traditionally spent more attention on the study of shivering thermogenesis 
(24), and important gaps remain regarding the human physiological responses to mild 
cold exposure in terms of EE and metabolic fuels selection (12). We hypothesized that a 
mild cold exposure designed to elicit non-shivering thermogenesis would exert light, but 
clinically meaningful if maintained in time, modifications on EE and metabolic fuels 
selection. Thus, the present study aimed to describe the EE and macronutrient oxidation 







Two different cohorts took part in this study (table 1). For the first cohort (thereinafter 
called study 1), 63 participants (45 female) were included in the study, all of them being 
part of the ACTIBATE study (25). However, only 44 out of 63 were included in the 
statistical analyses (Figure 1, see the reasons below). Study 1 was conducted in October 
and November 2016. For study 2, 13 participants were recruited and evaluated between 
December 2017 and January 2018. Inclusion criteria in both studies were: <35 years old, 
report being healthy, non-smoker and not taking any medication, have had a stable body 
weight (<3 Kg change) during the past 3 months, and not regularly exposed to cold. The 
study and written informed consent considered the last revision of the Declaration of 
Helsinki and were approved by the Human Research Ethics Committee of the University 
of Granada (nº924) and of the Servicio Andaluz de Salud (Centro de Granada, CEI-
Granada). 
We used a dual X-ray absorptiometry scan (Discovery Wi, Hologic, Inc., Bedford, MA, 
USA) to assess body composition, while a Seca scale and a stadiometer (model 799, 
Electronic Column Scale, Hamburg, Germany) were used to measure weight and height, 
respectively. 
Previous conditions to the study days 
Participants attended to the research center on two separate occasions. During the first 
visit, the individual’s shivering threshold was assessed while during the second visit CIT 
was measured. They were asked to sleep as usual, to avoid both moderate (24 hours) and 
vigorous (48 hours) physical activity prior to the testing days, and to commute by 





In study 1, participants fasted for at least 6 hours; 9±3.7 hours. Only those participants 
strictly following the fasting time indications (i.e. between 6 and 8 hours; n=18) were 
included in the macronutrient oxidation rate analyses (26, 27) (table 1). In study 2, 
participants were instructed to consume a standardized meal (35% of estimated total EE; 
boiled rice, tomato sauce, and omelet) 10 hours before the CIT assessment. Moreover, 
they were instructed to collect all the urine from the standardized meal to the CIT 
assessment start (i.e. 10 hours urine production). Another urine sample was collected 
immediately after the CIT assessment. 
Shivering threshold test (day 1) 
The shivering threshold assessment methodology has been extensively described 
elsewhere (23, 28). In brief, after voiding, the participants dressed-up with standardized 
clothes (clothing insulation value: 0.20). They then entered a warm room (22.1±1.6ºC) 
where they remained seated for 30 minutes, before entering a cold room (19.8±0.5ºC), 
where they dressed-up with a temperature-controlled water perfused cooling vest (Polar 
Products Inc., Ohio, USA). The vest circulating-water temperature was initially set at 
16.6ºC and was decreased every 10 minutes until 3.8ºC was reached or until shivering 
occurred. Shivering was determined visually and self-reported. The vest circulating-water 
temperature when shivering started was considered as the shivering threshold. 
CIT and cold-induced macronutrient oxidation rates (day 2) 
Participants returned to the lab (the same time of day as before) 5-7 days (study 1) or 2 
days (study 2) after the shivering threshold test. After voiding, they dressed in the same 
standardized clothes and entered a warm (23.2±0.7ºC) room. Before assessing EE, all 
participants reclined in a bed for 20 minutes. Later, their RMR was assessed over 30 





participants walked into the cold room (19.7±0.4ºC) and dressed in the cooling vest set at 
4ºC above the participant’s shivering threshold. They laid in a reclined bed while the CIT 
assessment was carried out for two 30-minute periods, separated by a 5-minute pause. 
For assessing RMR and CIT, ventilatory gas exchange was collected by using a neoprene 
face-mask hooked up to a CCM Express or Ultima CardiO2 metabolic cart (Medgraphics 
Corp, Minnesota, USA) (30, 31). Flow, at the beginning of every test day, and gas 
analyzers, before every 30-minute assessment, were calibrated following the 
manufacturer´s instructions. 
In study 1, despite of the careful assessment of shivering threshold, 17 (16 women) out 
of 63 participants shivered during the CIT assessment. Those individuals were excluded 
from further statistical analysis. Moreover, 2 males were also excluded from the analyses 
for presenting respiratory exchange ratio (RER) values higher than 1.1 or lower than 0.7 
in any measure point (29) (Figure 1). 
CIT and macronutrient oxidation rates estimation 
Oxygen consumption (VO2) and carbon dioxide production (VCO2) were downloaded 
from the metabolic cart software (Breeze Suite, 8.1.0.54 SP7) every minute. In all 30-
minute record period we discarded the first 5-minute record. We then selected the most 
stable 5-minute period among the remaining records (25 minutes) to be considered as the 
RMR, as previously described (30, 32). For calculating CIT, data was averaged every 5 
minutes. In addition, we divided the CIT record into 4 parts and selected the most stable 
5-minute period within every part. Finally, we calculated the area under the curve 
(trapezoidal rule) using the 4 selected 5-minute periods and the RMR, expressing it as a 
percentage of RMR. We have previously published that this method for data analyses 
resulted in more plausible estimations when compared to other methods for data analyses 





equation (35) (not taking into account any urinary nitrogen in study 1) were used for 
estimating carbohydrates (CHOox) (b) and fat oxidation (FATox) (c).  
(a) 𝐸𝐸𝐸𝐸 (Kcal/min) = 3.941 × 𝑉𝑉𝑉𝑉2(l/min) + 1.106 × 𝑉𝑉𝑉𝑉𝑉𝑉2 (l/min) – 2.17 x N(g/min)  
(b) 𝑉𝑉𝐶𝐶𝑉𝑉𝐶𝐶𝐶𝐶 (g/min) = −3.21 × 𝑉𝑉𝑉𝑉2 (l/min) + 4.55 × 𝑉𝑉𝑉𝑉𝑉𝑉2 (l/min) – 2.87 x N(g/min) 
(c) 𝐹𝐹𝐹𝐹𝐹𝐹𝐶𝐶𝐶𝐶 (g/min) = 1.67 ×  𝑉𝑉𝑉𝑉2 (l/min)− 1.67 × 𝑉𝑉𝑉𝑉𝑉𝑉2 (l/min) - 1.92 x N(g/min) 
In study 2, we measured total urine volume and urea concentration in both urine samples. 
Thereafter, we estimated nitrogen urine levels from the urea concentration (Spinreact, 
Catalogue No. 283-17) following the equation "N(g/l) = 0.0065* Urea(mg/dl) + 1.2598" 
obtained from a linear regression including urea and nitrogen measured concentrations 
(kjeldahl method (36)) from an independent cohort of young healthy adults (n=19, 16 
women; 21.87±2.05 years old; 24.87±3.71 kg/m2). Protein oxidation (g/min) was 
calculated as N(g/min) x 6.25 (37). 
Statistical analysis 
Repeated-measures analyses of variance (ANOVA), with Bonferroni post-hoc 
corrections, were used to test differences in EE, CHOox and FATox across time. Paired 
t-test were used to compare protein oxidation before and during the cold stimulus. 
The analyses were conducted using the Statistical Package for Social Sciences (SPSS, v. 
21.0, IBM SPSS Statistics, IBM Corporation). Figures were created using Graph Pad 







Mild cold exposure significantly increased EE (P<0.001; Figure 2A) from the beginning 
of cold-exposure and remained stable from that moment till the end of the mild cold 
exposure. Mean overall CIT estimation was 13.9±11.6 %RMR (Range: -14.8/39.9 
%RMR, Figure 2B). When translated to cumulative EE (i.e. the total amount of energy 
above the RMR expended during the whole 65-minute cold exposure), it resulted in 
9.56±7.9 Kcal. 
CHOox decreased after 30 minutes of mild cold exposure (P=0.001), although its level 
returned to the baseline after 40 minutes of mild cold exposure (Figure 2F). The peak 
FATox was observed at 30 minutes of cold exposure (P<0.001; Figure 2F). FATox 
progressively increased until minute 30, and later on, there was a decrease. All results 
were similar in men and women, and in individuals with BMI<25kg/m2 and 
BMI>25kg/m2 (data not shown). Mean overall CI CHOox was -7.3±22.5%basalCHOox 
(Range: -36.4/34.31 % basalCHOox) and mean overall CI FATox was 53.6±90.9 
%basalFATox (Range: -33.9/382.1 % basalFATox). 
Figure 3 shows EE and macronutrient oxidation rates during a mild cold exposure in the 
study 2. Cold exposure increased EE as in study 1 (P>0.001; Figure 3A). The effect of 
cold exposure on both CHOox and FATox (Figure 3F) was also similar to study 1. Finally, 
Figure 4 shows the estimated protein oxidation before (10 hours) and during the mild cold 
exposure in study 2. Mild cold exposure significantly increased protein oxidation 
(0.91±0.38 g/min during the cold exposure vs. 0.54±0.29 g/min for the 10h preceding 







We show that a 1 hour individualized mild cold exposure produced a moderate increase 
in energy expenditure (9.56±7.9 Kcal/h) in young healthy adults. Interestingly, we 
observed a metabolic shift in time for sustaining CIT. CHOox decreased during the first 
30 minutes of the cold exposure and recovered up to the baseline values at the end of the 
cold exposure. In contrast, FATox continuously increased during the first 30 minutes, and 
decreased in the second part of the cold exposure. Of note is that these results were 
replicated in two independent studies which further reinforce the findings. Our results 
show a modest EE increase during mild cold exposure which concurs with previous 
studies (12). Our data also show a previously unreported shift in the nutrient oxidation 
rates for sustaining the CIT during the first phase of mild cold exposure (first 30 minutes). 
This finding might have important implications for the understanding of physiological 
processes underlying human non-shivering thermogenesis. 
Mild cold exposure induces moderate increases in energy expenditure  
In study 1, some individuals showed negative values of CIT (i.e. lower EE in cold than 
in RMR) while others experienced a 39% increase over RMR, which concurs with the 
huge inter-individual variability (38, 39) reported in previous studies. Whether non-
shivering cold exposure induces a stable energy expenditure change from the beginning 
of the exposure is unclear (40). We observed that when applying an individualized 
cooling protocol at a temperature near to the shivering threshold, maximum non-shivering 
thermogenesis appears to be elicited from the beginning of the cold exposure. This 
constant thermogenic rate concurs with other studies analyzing the EE elicited by 
shivering (41, 42). On the other hand, it is not clear whether the magnitude of non-
shivering thermogenesis is able to induce a significant negative energy balance (14, 43). 





shivering thermogenesis, all participants presented an EE below 1.4 metabolic equivalent 
(MET, i.e. 40% of RMR increase). Taking into account that even a very low intensity 
exercise, such as walking, can elicit 2-3 METs, together with the fact that cold exposure 
may induce an hyperphagic response (44), it seems that cold exposure at temperatures 
eliciting low shivering and maximum non-shivering thermogenesis are not an efficient  
stimuli to induce negative energy balance. It should also be noted that this mild cold 
stimulus produces a considerable burden and discomfort for participants, despite only 
9.56±7.9 Kcal were burned (above the RMR) after an hour at this uncomfortable situation. 
Nonetheless, if maximum non-shivering thermogenesis were induced by pharmacological 
or nutraceutical agents (45, 46), instead of cold exposure, and were continuously elicited 
during 24h, our data would translate into 212±175 Kcal/day. Importantly, recent studies 
using radiotracers for the quantification of BAT energy expenditure have estimated that, 
if maximally and continually activated, human BAT could account for as much as ≈15 
Kcal/day (20, 47, 48). This is less than 10% of the 24h CIT estimation made in our study, 
which suggest that tissues other than BAT (e.g. skeletal muscle) may represent better 
targets for stimulating non-shivering thermogenesis in humans (5). Nonetheless, 
alternative mechanisms beyond energy balance (9, 10) have been suggested to mediate 
the health promoting effects of BAT and chronic cold exposure (6–8). Therefore, mild 
cold exposure and/or pharmacological BAT activation or recruitment might not be 
discarded as possible therapeutic target including insulin sensitizing effects. 
Mild cold exposure induced a shift on fuel oxidation 
We observed a marked shift in macronutrient oxidation to sustain the thermogenic rate. 
Previous studies have reported similar metabolic shifts at a constant thermogenic rate in 
response to cold (in shivering conditions) (12, 41, 42), however, we observed a decrease 





to have a profound impact on cold endurance, and therefore on cold survival (12). 
Consequently, fatty acids are the most sustainable fuel for thermogenic purposes. FATox 
is the predominant substrate for both non-shivering and shivering thermogenesis (12). 
Therefore, it is biologically plausible that a shift to FATox is produced when thermogenic 
needs are not maximized, such as at the beginning of the cold exposure. 
BAT is not the only contributor responsible for non-shivering thermogenesis in humans.  
Skeletal muscle possibly contributes to non-shivering thermogenesis even to a larger 
extent (14, 20). Although both BAT and skeletal muscle preferentially use fatty acids as 
energy fuel in non-shivering situations, BAT is probably more FATox-preferential, as 
more than 90% of its energy consumption relies on fat oxidation (49, 50), while skeletal 
muscle presents a more balanced nutrient uptake (12). Therefore, it is plausible to 
speculate with the possibility of BAT being the main contributor to CIT at initial stages 
of mild cold exposure while muscle contribution to CIT would increase progressively, 
therefore balancing the contribution of CHOox and FATox. This hypothesis is supported 
by recent studies showing that BAT is rapidly activated upon cold exposure and seems to 
stabilize after 35 minutes of cold exposure (51–53). Moreover, we previously reported a 
high prevalence of BAT in study 1 (88% BAT positive, BAT volume=94.4±59.6 ml), 
measured by static 18F-Flurodeoxyglucose PET/CT scan after 2 hours of personalized 
cold exposure, in study 1 participants (23, 54); therefore BAT thermogenesis was likely 
induced during the mild cold exposure. New studies examining the contribution of both 
tissues, BAT and skeletal muscle, from the very beginning of the cold exposure are 
needed to confirm such hypothesis. 
Protein oxidation was only assessed in study 2, in which we observed a significant 
increase in response to mild cold exposure. A recent study in both mice and humans 





branched-chain amino acids (BCAA) (55). Importantly, blunting BCAA oxidation in 
BAT significantly affected BAT thermogenic capacity in mice (55). Therefore, the 
increase of protein oxidation observed in our study might be explained by the increased 
uptake and oxidation of BCAA in BAT. Such statement is quite speculative since we did 
not specifically measure BCAA oxidation in study 2. Further studies are needed to test 
whether there is an association between BAT activity and cold-induced protein oxidation 
in humans. 
In agreement with previous studies (12), we observed a considerable high inter-individual 
variability in cold-induced macronutrient oxidation rates. In human studies, different 
patterns of shivering (i.e. muscle recruitment) explain most of the inter-individual 
variability in cold-induced macronutrient oxidation rates (12, 41, 42). Since the protocol 
we applied is considered to result in low shivering contribution to CIT, different patterns 
of shivering may not explain such a large inter-individual variability. Alternatively, inter-
individual differences on tissues (BAT, skeletal muscle, and white adipose tissue) relative 
contribution to CIT (i.e. proportion of CIT being produce by each tissue) might partially 
explain such a high inter-individual difference (5). 
Limitations 
In study 1, carbohydrates and fat oxidation rates were calculated without considering 
protein oxidation, since we did not measure urine nitrogen excretion. In addition, in study 
1, we did not strictly control fasting period and previous meal content. However, we 
performed a confirmatory study (i.e. study 2) analyzing protein oxidation and strictly 
controlling fasting time, previous meal content and similar results were found. Secondly, 
the visually detected or self-reported shivering is likely to occur after electrical muscle 
activity (40). Therefore, the absence of electromyographical recording might have 





participants presenting detectable shivering during the CIT assessment, we cannot discard 
that non-visually detectable nor self-noted shivering thermogenesis was present (14). 
Nonetheless, it is probable that non-shivering thermogenesis was the predominant form 
of CIT in the included participants. In addition, it should be noted that the study sample 
was entirely composed of young (18-32 years) healthy individuals, and thus the results 
cannot be generalized to older or unhealthy individuals. Finally, it should be noted that 
the reliability of the indirect calorimeters used in this study was not optimal (31). This 
probably explains the presence of non-physiological values obtained in 2 out of our 63 






A mild cold exposure at a temperature adjusted to elicit maximum non-shivering 
thermogenesis induces a very modest increase in EE (<40% RMR; ≈1.4 METs), which is 
maintained constant during an hour. The cumulated cold-induced energy expenditure 
over an hour of mild cold exposure (9.6±7.9 Kcal/h) is probably insufficient to induce a 
negative energy balance in humans. However, we cannot exclude that sustained induction 
of maximum non-shivering cold-induced thermogenesis (212±175 Kcal/day), which 
might be achieved by pharmacological or nutraceutical agents, can be a feasible strategy 
for weight loss. Interestingly, we found a metabolic shift on macronutrient oxidation rates 
to sustain CIT by which FATox increased in parallel to a decrease in CHOox at the 
beginning of cold exposure. Later, an inverse tendency appeared by which CHOox 
increased and FATox slightly decreased. This may indicate that tissues playing a key role 
in CIT (i.e. BAT and muscles) could be different during the first stages of cold exposure 
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Table 1. Participants’ characteristic. 
 
Study 1 CIT 
analyses (n=44) 
Study 1 NUTox 
analyses (n=18) 
Confirmatory study 
(Study 2, n=13) 
Sex (n women. %) 29 (65.9) 13.0 (72.2) 6.0 (46.2) 
Age (years) 22.2 (2.2) 21.9 (2.0) 25.6 (3.0) 
BMI (kg/m2) 25.6 (5.3) 24.3 (4.6) 23.6 (2.4) 
Lean mass (Kg) 42.7 (10.4) 40.4 (8.0) 45.7 (13.3) 
Fat mass (Kg) 27.2 (10.6) 25.0 (9.6) 18.4 (3.8) 
Fat mass percentage (%) 37.0 (8.0) 36.1 (7.0) 28.4 (6.6) 
RMR (Kcal/day) 1565 (278) 1554 (227) 1484 (286) 
RER 0.862 (0.054) 0.842 (0.048) 0.833 (0.036) 
Cooling vest water temperature (ºC) 8.4 (3.5) 9.2 (3.8) 12.1 (3.1) 
Data are means (standard deviation) except for sex. CIT: Cold-induced thermogenesis; NUTox: 
Macronutrient oxidation rates; BMI: Body mass index; RMR: Resting Metabolic Rate; RER: 







Figure 1. Participant´s flow-chart. ACTIBATE: Activating brown adipose tissue through 
exercise; BMI: body mass index, CIT: Cold-induced thermogenesis; ECG: electrocardiogram; 
NUTox: Nutrient oxidation, RER: Respiratory exchange ratio. 
Figure 2. Cold-induced thermogenesis (CIT) and macronutrient oxidation rates (study 1). 
Panels A (adapted from (33)) C and D: Minute 0 represents the resting metabolic rate (RMR). 
Values are mean and standard error of the mean. P values for the main effect of the repeated 
measures ANOVAs. * represent values significantly different than RMR. Panel B: histogram 
representing over-all CIT (each column representing one individual´s CIT). Dashed line 
represents mean CIT. CHOox: carbohydrates oxidation; FATox: fat oxidation; Kcal: 
Kilocalories; min: minutes; RER: respiratory exchange ratio; VO2: oxygen consumption; 
VCO2: carbon dioxide production. 
Figure 3. Cold-induced thermogenesis (CIT) and macronutrient oxidation rates (study 2). 
Panels A, C and D: Minute 0 represents the resting metabolic rate (RMR). Values are mean 
and standard error of the mean. P values for the main effect of the repeated measures 
ANOVAs. Panel B: histogram representing over-all CIT (each column representing one 
individual´s CIT). Dashed line represents mean CIT. CHOox: carbohydrates oxidation; 
FATox: fat oxidation; Kcal: Kilocalories; min: minutes; RER: respiratory exchange ratio; 
VO2: oxygen consumption; VCO2: carbon dioxide production. 
Figure 4. Protein oxidation before (10 hours) and during mild cold exposure in the study 2. P 
value is for paired t-test. 
